ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 680

$1.02M Total Retail Price of All Prescriptions

Rank: 78 out of 680

772 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 772 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 772 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 15,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 728 656 1 3
AMLODIPINE BESYLATE 667 613 2 1
LEVOTHYROXINE SODIUM 659 597 3 2
LOSARTAN POTASSIUM 557 517 4 21
HYDROCODONE-ACETAMINOPHEN 541 368 S3 5 4
METFORMIN HCL ER 473 427 6 54
ATORVASTATIN CALCIUM 470 423 7 11
OMEPRAZOLE 420 375 8 7
HYDROCHLOROTHIAZIDE 367 347 9 9
CRESTOR 308 270 10 25
ZOLPIDEM TARTRATE 305 262 11 17
LISINOPRIL 302 274 12 5
FUROSEMIDE 279 256 13 6
LOSARTAN-HYDROCHLOROTHIAZIDE 272 239 14 51
ATENOLOL 233 222 15 19
GLIMEPIRIDE 229 221 16 29
MELOXICAM 221 201 17 24
ALLOPURINOL 212 207 18 33
SYNTHROID 205 173 19 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 181 170 20 37
TRAMADOL HCL 172 148 21 18
DONEPEZIL HCL 159 146 22 27
METFORMIN HCL 143 120 23 8
METOPROLOL SUCCINATE 138 122 24 13
GABAPENTIN 136 106 25 15
TAMSULOSIN HCL 129 119 26 34
CITALOPRAM HBR 126 120 27 22
ALPRAZOLAM 126 90 27 72
AMLODIPINE BESYLATE-BENAZEPRIL 124 123 29 43
METOPROLOL TARTRATE 121 93 30 12
POTASSIUM CHLORIDE 120 99 31 14
SERTRALINE HCL 115 91 32 28
CLONAZEPAM 109 87 33 190
AMITRIPTYLINE HCL 103 95 R 34 47
PEN NEEDLE 103 91 34 122
ESCITALOPRAM OXALATE 103 77 34 45
CYMBALTA 102 47 37 46
CLOPIDOGREL 99 84 38 26
DOXAZOSIN MESYLATE 99 85 38 73
FLUOXETINE HCL 95 85 40 74
NEXIUM 95 83 40 16
SPIRONOLACTONE-HCTZ 95 95 40 259
LOVASTATIN 94 94 43 44
FLUTICASONE PROPIONATE 94 91 43 41
PANTOPRAZOLE SODIUM 92 83 45 30
BYSTOLIC 91 91 46 79
LIPITOR 91 85 46 68
DIOVAN HCT 91 89 46 55
BENAZEPRIL HCL 90 70 49 40
DIOVAN 86 86 50 31
QUINAPRIL HCL 84 84 51 104
BUPROPION XL 84 77 51 161
BENICAR 83 71 53 131
ESTRADIOL 81 68 R 54 134
LEVOFLOXACIN 81 72 54 97
SPIRIVA 78 78 56 70
ALENDRONATE SODIUM 77 77 57 32
LANTUS SOLOSTAR 76 73 58 84
CELEBREX 75 67 59 90
BISOPROLOL-HYDROCHLOROTHIAZIDE 75 73 59 156
CEFDINIR 74 49 61 212
WARFARIN SODIUM 74 74 61 20
VERAPAMIL ER 74 74 61 100
FELODIPINE ER 72 68 64 146
SPIRONOLACTONE 71 65 65 82
CIPROFLOXACIN HCL 70 61 66 57
PRAVASTATIN SODIUM 70 70 66 10
TRIAMTERENE-HCTZ 69 69 68 52
AZITHROMYCIN 68 56 69 42
PAROXETINE HCL 68 53 69 76
CARVEDILOL 67 67 71 23
ADVAIR DISKUS 66 62 72 53
PLAVIX 65 52 73 39
VYTORIN 64 61 74 152
TRAZODONE HCL 63 63 75 48
PREDNISONE 62 59 76 50
ZOSTAVAX 57 51 77 230
PROPRANOLOL HCL 57 54 77 145
BENICAR HCT 55 54 79 150
ONGLYZA 55 52 79 136
ZETIA 54 54 81 87
DIGOXIN 51 51 82 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.